Chen HW - Search Results

1

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.

Li QJ, He MK, Chen HW, Fang WQ, Zhou YM, Xu L, Wei W, Zhang YJ, Guo Y, Guo RP, Chen MS, Shi M. Li QJ, et al. Among authors: chen hw, chen ms. J Clin Oncol. 2022 Jan 10;40(2):150-160. doi: 10.1200/JCO.21.00608. Epub 2021 Oct 14. J Clin Oncol. 2022. PMID: 34648352 Clinical Trial.

2

[Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].

Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ. Xu ZM, et al. Among authors: chen hw. Nan Fang Yi Ke Da Xue Xue Bao. 2006 Nov;26(11):1626-8. Nan Fang Yi Ke Da Xue Xue Bao. 2006. PMID: 17121718 Chinese.

3

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma.

He MK, Liang RB, Zhao Y, Xu YJ, Chen HW, Zhou YM, Lai ZC, Xu L, Wei W, Zhang YJ, Chen MS, Guo RP, Li QJ, Shi M. He MK, et al. Among authors: chen hw, chen ms. Ther Adv Med Oncol. 2021 Mar 25;13:17588359211002720. doi: 10.1177/17588359211002720. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33854567 Free PMC article.

4

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study.

Chen S, Wu Z, Shi F, Mai Q, Wang L, Wang F, Zhuang W, Chen X, Chen H, Xu B, Lai J, Guo W. Chen S, et al. J Cancer Res Clin Oncol. 2022 Aug;148(8):2115-2125. doi: 10.1007/s00432-021-03767-4. Epub 2021 Aug 28. J Cancer Res Clin Oncol. 2022. PMID: 34453221 Free PMC article.

5

Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma.

Xu YJ, Lai ZC, He MK, Bu XY, Chen HW, Zhou YM, Xu L, Wei W, Zhang YJ, Chen MS, Guo RP, Shi M, Li QJ. Xu YJ, et al. Among authors: chen hw, chen ms. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211063848. doi: 10.1177/15330338211063848. Technol Cancer Res Treat. 2021. PMID: 34898313 Free PMC article.

6

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.

Li SH, Mei J, Cheng Y, Li Q, Wang QX, Fang CK, Lei QC, Huang HK, Cao MR, Luo R, Deng JD, Jiang YC, Zhao RC, Lu LH, Zou JW, Deng M, Lin WP, Guan RG, Wen YH, Li JB, Zheng L, Guo ZX, Ling YH, Chen HW, Zhong C, Wei W, Guo RP. Li SH, et al. Among authors: chen hw. J Clin Oncol. 2023 Apr 1;41(10):1898-1908. doi: 10.1200/JCO.22.01142. Epub 2022 Dec 16. J Clin Oncol. 2023. PMID: 36525610 Free PMC article. Clinical Trial.

7

Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study.

Deng M, Lei Q, Wang J, Lee C, Guan R, Li S, Wei W, Chen H, Zhong C, Guo R. Deng M, et al. Int J Surg. 2023 May 1;109(5):1299-1310. doi: 10.1097/JS9.0000000000000376. Int J Surg. 2023. PMID: 37038994 Free PMC article.

8

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study.

Chen S, Shi F, Wu Z, Wang L, Cai H, Ma P, Zhou Y, Mai Q, Wang F, Tang S, Zhuang W, Lai J, Chen X, Chen H, Guo W. Chen S, et al. J Hepatocell Carcinoma. 2023 Jul 27;10:1209-1222. doi: 10.2147/JHC.S417550. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37533600 Free PMC article.

9

Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study.

Guo Z, Liu Y, Ling Q, Xu L, Wang T, Zhu J, Lin Y, Lu X, Qu W, Zhang F, Zhu Z, Zhang J, Jia Z, Zeng P, Wang W, Sun Q, Luo Q, Hu Z, Zheng Z, Jia Y, Li J, Zheng Y, Wang M, Wang S, Han Z, Yu S, Li C, Zhang S, Xiong J, Deng F, Liu Y, Chen H, Wang Y, Li L, Liang W, Schlegel A, Nashan B, Liu C, Zheng S, He X. Guo Z, et al. Am J Transplant. 2024 Apr 18:S1600-6135(24)00278-8. doi: 10.1016/j.ajt.2024.04.007. Online ahead of print. Am J Transplant. 2024. PMID: 38642712

10

Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study.

Qiao L, He W, Wang G, Chen H, Huang F, Zhang B, Qiu Y, Liu S, Huang Z, Yuan Y, Qiu J, Yuan Y, Li B. Qiao L, et al. Cancer Med. 2024 May;13(9):e7236. doi: 10.1002/cam4.7236. Cancer Med. 2024. PMID: 38716585 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,661 results

Search Page